Skip to content
Takeda Pharmaceuticals
-
-
-
-
-
-
-
-
Takeda Pharmaceutical withdraws US application for Dengue vaccine
USA — In a recent development, Takeda Pharmaceutical has voluntarily withdrawn its application seeking US approval for its dengue vaccine. The decision came after discussions…
-
Rare disease company Takeda rolls out its new public health initiatives in India
INDIA – Takeda Biopharmaceuticals India Private Limited has launched its latest public health initiatives aimed at strengthening the health system for rare diseases (RD) in…
-
Takeda ramps up production capacity for plasma-derived therapies with US$765M investment in Japanese facility
JAPAN —Takeda Pharmaceutical Company Limited has announced that it will invest approximately US$764.6 million to construct a new manufacturing facility for plasma-derived therapies (PDTs) in…